Division of Biochemical Toxicology , FDA National Center for Toxicological Research , Jefferson , Arkansas 72079 , United States.
Centro de Química Estrutural, Instituto Superior Técnico , ULisboa , 1049-001 Lisboa , Portugal.
Chem Res Toxicol. 2019 May 20;32(5):869-877. doi: 10.1021/acs.chemrestox.9b00020. Epub 2019 Mar 12.
Acrylamide has been classified as a "Group 2A carcinogen" (probably carcinogenic to humans) by the International Agency for Research on Cancer. The carcinogenicity of acrylamide is attributed to its well-recognized genotoxicity. In the present study, we investigated the effect of acrylamide on epigenetic alterations in mice. Female B6C3F1 mice received acrylamide in drinking water for 28 days, at doses previously used in a 2 year cancer bioassay (0, 0.0875, 0.175, 0.35, and 0.70 mM), and the genotoxic and epigenetic effects were investigated in lungs, a target organ for acrylamide carcinogenicity, and livers, a nontarget organ. Acrylamide exposure resulted in a dose-dependent formation of N7-(2-carbamoyl-2-hydroxyethyl)guanine and N3-(2-carbamoyl-2-hydroxyethyl)adenine in liver and lung DNA. In contrast, the profiles of global epigenetic alterations differed between the two tissues. In the lungs, acrylamide exposure resulted in a decrease of histone H4 lysine 20 trimethylation (H4K20me3), a common epigenetic feature of human cancer, while in the livers, there was increased acetylation of histone H3 lysine 27 (H3K27ac), a gene transcription activating mark. Treatment with 0.70 mM acrylamide also resulted in substantial alterations in the DNA methylation and whole transcriptome in the lungs and livers; however, there were substantial differences in the trends of DNA methylation and gene expression changes between the two tissues. Analysis of differentially expressed genes showed a marked up-regulation of genes and activation of the gene transcription regulation pathway in livers, but not lungs. This corresponded to increased histone H3K27ac and DNA hypomethylation in livers, in contrast to hypermethylation and transcription silencing in lungs. Our results demonstrate that acrylamide induced global epigenetic alterations independent of its genotoxic effects, suggesting that epigenetic events may determine the organ-specific carcinogenicity of acrylamide. Additionally this study provides strong support for the importance of epigenetic alterations, in addition to genotoxic events, in the mechanism of carcinogenesis induced by genotoxic chemical carcinogens.
丙烯酰胺已被国际癌症研究机构归类为“2A 组致癌物”(可能对人类致癌)。丙烯酰胺的致癌性归因于其公认的遗传毒性。在本研究中,我们研究了丙烯酰胺对小鼠表观遗传改变的影响。雌性 B6C3F1 小鼠通过饮用水接受丙烯酰胺 28 天,剂量为之前进行的 2 年癌症生物测定中使用的剂量(0、0.0875、0.175、0.35 和 0.70mM),并研究了靶器官肺和非靶器官肝中的遗传毒性和表观遗传效应。丙烯酰胺暴露导致肝和肺 DNA 中 N7-(2-氨甲酰基-2-羟乙基)鸟嘌呤和 N3-(2-氨甲酰基-2-羟乙基)腺嘌呤的形成呈剂量依赖性。相比之下,两种组织之间的全球表观遗传改变谱不同。在肺部,丙烯酰胺暴露导致组蛋白 H4 赖氨酸 20 三甲基化(H4K20me3)减少,这是人类癌症的常见表观遗传特征,而在肝脏中,组蛋白 H3 赖氨酸 27 乙酰化(H3K27ac)增加,这是一种基因转录激活标记。用 0.70mM 丙烯酰胺处理还导致肺部和肝脏中的 DNA 甲基化和整个转录组发生实质性改变;然而,两种组织之间的 DNA 甲基化和基因表达变化趋势存在很大差异。差异表达基因分析显示,肝脏中基因表达明显上调,基因转录调控途径被激活,但肺部没有。这与肝脏中组蛋白 H3K27ac 和 DNA 去甲基化增加相对应,而肺部则是过度甲基化和转录沉默。我们的结果表明,丙烯酰胺诱导了独立于其遗传毒性作用的全基因组表观遗传改变,表明表观遗传事件可能决定丙烯酰胺的器官特异性致癌性。此外,该研究为遗传毒性化学致癌物致癌机制中除遗传毒性事件外,还包括表观遗传改变的重要性提供了有力支持。